Stocktoria

ACTUATE THERAPEUTICS, INC. ACTU

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-08-13

ACTUATE THERAPEUTICS, INC. statistics & valuation

Market cap$40.2M
P / B5.1×
Return on capital-270.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202320242025
Operating margin (%)
202320242025
Return on equity (%)
-26189.10% -280.50% 202320242025
Shares outstanding
1.7M 19.5M 23.2M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-826.00% -292.80% -158.40% 202320242025
Free cash flow margin (%)
202320242025
Debt / equity (×)
202320242025
EPS ($)
-$17.24 -$3.26 -$1.06 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Return on assets-158.4%-292.8%-826.0%
Return on equity-280.5%-26189.1%24.8%
Current ratio2.391.050.43

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.